Upcoming Presentation - Stocks of the Day

Stocks of the Day

Sign In / Sign Up

Latest News
Stock Screener
AI Signals
News Archive
Membership
About
- About
- FAQ
- Blog
- Contact Us

Latest News
Stock Screener
AI Signals
News Archive
Membership
About
- About
- FAQ
- Blog
- Contact Us

Register Free
Sign in

Search mobile

Topic :

Upcoming Presentation

OTC, STEK

#Upcoming Presentation

STEMTECH CORPORATION INVITED TO PRESENT AT ROTH CAPITAL HEALTHCARE OPPORTUNITIES CONFERENCE IN NEW YORK CITY

October 4, 2022
09:00

EST

MIRAMAR, FL, Oct. 04, 2022 (GLOBE NEWSWIRE) — Stemtech Corporation (“Stemtech”) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today that it was invited to present at the Roth Capital Healthcare Opportunities Conference in New York City on October 6. Stemtech

No Comments

OTC, PGNRF

#Upcoming Presentation

Pan Global Announces Webinar to Provide an Overview of Its Drill Program on Multiple New Copper Targets in the Escacena Project, Spain

October 4, 2022
09:00

EST

Vancouver, British Columbia–(Newsfile Corp. – October 4, 2022) – Pan Global Resources Inc. (TSXV: PGZ) (OTC Pink: PGNRF) (“Pan Global” or the “Company”) is pleased to announce that it will be hosting a live Webinar on Wednesday, October 5, 2022 at 9 a.m. PST / 12 p.m. EST. President

No Comments

DYAI, NASDAQ

#Expansion #Influenza #Upcoming Clinical Trial Presentation #Upcoming Presentation

Dyadic to Present Disruptive C1 Technology at World Vaccine Congress Europe Announcing Expansion of Influenza Pipeline with Enhanced Efficacy Potential

October 4, 2022
08:45

EST

JUPITER, Fla., Oct. 04, 2022 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein production and unmet clinical needs for effective and affordable biopharmaceutical products for human and

No Comments

LMFA, NASDAQ

#Bitcoin #Upcoming Presentation

LM Funding to Present at Dawson James Securities 7th Annual Small Cap Growth Conference on October 12th

October 4, 2022
08:30

EST

TAMPA, FL, Oct. 04, 2022 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ:LMFA) (“LM Funding” or “LMFA”) announced today that Bruce Rodgers, Chairman, President and CEO and Richard Russell, Chief Financial Officer of LM Funding, will present at the Dawson James Securities 7th Annual Small Cap Growth Conference on October 12,

No Comments

NASDAQ, TNYA

#Upcoming Presentation

Tenaya Therapeutics to Present Preclinical Data on Its Novel Engineered AAV Capsids for Cardiac Gene Delivery at the ESGCT 29th Annual Congress

October 4, 2022
08:30

EST

SOUTH SAN FRANCISCO, Calif., Oct. 04, 2022 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, announced today that it will present new preclinical data on its

No Comments

AMEX, LCTX

#Upcoming Presentation

Lineage to Present at Alliance for Regenerative Medicine 2022 Cell & Gene Meeting on the Mesa

October 4, 2022
08:00

EST

CARLSBAD, Calif.–(BUSINESS WIRE)–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that Brian M. Culley, Lineage’s Chief Executive Officer, will present at the Alliance for Regenerative Medicine 2022 Cell & Gene Meeting on the Mesa,

No Comments

NEXCF, OTC

#Metaverse #Upcoming Presentation

Nextech AR to Present Thursday October 6 At The VirtualInvestorConferences.com

October 4, 2022
07:30

EST

TORONTO–(BUSINESS WIRE)–Nextech AR Solutions Corp. (“Nextech” or the “Company”) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), a Metaverse Company and leading provider of augmented reality (“AR”) Wayfinding technologies, and 3D model services for the largest prime ecommerce platform announces that Evan Gappelberg, CEO will present live at VirtualInvestorConferences.com on Thursday,

No Comments

NASDAQ, PSTV

#Cancer #Upcoming Clinical Trial Presentation #Upcoming Presentation

Plus Therapeutics to Share Data in Oral Presentations from Ongoing ReSPECT™ Clinical Trials at the 35th Annual Congress of the European Association of Nuclear Medicine

October 4, 2022
07:15

EST

AUSTIN, Texas, Oct. 04, 2022 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today announced it will present data from two ongoing clinical trials evaluating the Company’s lead investigational targeted radiotherapeutic, Rhenium-186 NanoLiposome (186RNL), in

No Comments

CTSO, NASDAQ

#Upcoming Presentation

CytoSorbents to Present at the Dawson James Securities 2022 Small Cap Growth Conference

October 4, 2022
07:00

EST

PRINCETON, N.J., Oct. 4, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces that Dr. Phillip Chan, Chief Executive Officer, will present at the Dawson James Securities 2022 Small Cap Growth Conference on

No Comments

NASDAQ, TALS

#Upcoming Presentation

Talaris Therapeutics to Present at the 2022 Cell & Gene Meeting on the Mesa

October 4, 2022
07:00

EST

BOSTON and LOUISVILLE, Ky., Oct. 04, 2022 (GLOBE NEWSWIRE) — Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders, today announced that Scott Requadt, Chief Executive

No Comments

< Page1 Page2 Page3 … Page330 >

Trending News

Ginkgo Bioworks Acquires Adaptive Laboratory Evolution Company Altar

10/04/2022

Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic Medicine

10/03/2022

TRITON3 Phase 3 Trial of Rubraca® (rucaparib) Achieves Primary Endpoint in Men with Metastatic Castration-Resistant Prostate Cancer with BRCA or ATM Mutations

10/03/2022

BigBear.ai Awarded $14.8 Million U.S. Army Global Force Information Management System Contract

09/29/2022

Harsco Rail Signs Contract with Saudi Railway Company

09/29/2022

Most read news

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Twitter, Inc. – TWTR

09/24/2022

Arrival Produces First Production Verification Van in Microfactory

09/30/2022

Predictive Oncology Announces CEO Retirement

09/16/2022

© 2022 stocksoftheday.

Stocks of the Day does not provide investment advice. All rights reserved.

Tools

Predictions
Stock Screener
News Archive
News Feed
News Tags
Tickers
Trending Tickers
News Sentiments
Holidays & Trading Hours

Learn

FAQ
Guides
Infographics
Affiliate Program FAQ

Account

Sign In
Register
Email Preferences
Membership Option

Company

About
Contact Us
Careers
Blog
Privacy Policy
Terms of Use
Sitemap

Partnerships

Affiliate Program
Partnerships

Create account

Let the news trading begin!

or

Email

First Name

Last Name

Password

I agree with the Terms of Use and Privacy Policy.

Already have an account? Sign-In

Sign In

Let the news trading begin!

or

Email

Password

Remember me

Lost your password?

Not registered yet? Create a free account